Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zhaohui Liang
Indoleamine 2,3-Dioxygenase 1 and Programmed Cell Death-Ligand 1 Co-Expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy
Cancers
Cancer Research
Oncology
Increased Expression of microRNA-17 Predicts Poor Prognosis in Human Glioma
Journal of Biomedicine and Biotechnology
Related publications
Programmed Death-Ligand 1 Expression Correlates With Diminished CD8+ T Cell Infiltration and Predicts Poor Prognosis in Anal Squamous Cell Carcinoma Patients
Cancer Management and Research
Oncology
Increased Programmed Death Ligand-1 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients
OncoTargets and Therapy
Oncology
Pharmacology
Clinical Significance of Soluble Programmed Cell Death-1 and Soluble Programmed Cell Death-Ligand 1 in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy
PLoS ONE
Multidisciplinary
Up‐regulation of Indoleamine 2,3‐dioxygenase 1 (IDO1) Expression and Catalytic Activity Is Associated With Immunosuppression and Poor Prognosis in Penile Squamous Cell Carcinoma Patients
Cancer Communications
Cancer Research
Oncology
The Expression of Programmed Death Ligand-1 Within Stages of Oral Squamous Cell Carcinoma: Immunohistochemical Analysis
Journal of Advances in Medicine and Medical Research
Indoleamine 2,3-Dioxygenase 1 (IDO1)
Science-Business eXchange
High P53 and MAP1 Light Chain 3A Co-Expression Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Neoadjuvant vs Definitive Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Patients
World Journal of Surgical Oncology
Surgery
Oncology
Interplay Between the NF‑κB and Hedgehog Signaling Pathways Predicts Prognosis in Esophageal Squamous Cell Carcinoma Following Neoadjuvant Chemoradiotherapy
International Journal of Molecular Medicine
Medicine
Genetics
